当前位置:首页 > 关于我们 > 创投导师 > 衷兴华

衷兴华 | Zhong Xinghua


39.jpg

衷兴华

外科医生  法国Poitiers 大学MBA

中国某三甲医院院长,法国POITIERS大学医院院长助理。

曾成功投资过中国A股创业版和科创版多个TOP公司(海南普利制药和神州细胞公司),

曾任安徽华源药业董事长,海南普利制药监事长等。

曾参加上海质子重粒子放疗中心的项目引进论证工作。

曾策划和帮助知名投资机构和企业把钇90核素治疗肝癌技术引进到中国。

曾任中核同辐基金的独立专业投资决策委员。

衷兴华医生创立了会惠康全球肿瘤会诊网,帮助  肿瘤医生MDT会诊和新技术交流,致力于肿瘤医疗新技术的投资、产业化和推广应用。


Zhong Xinghua

Surgeon; MBA from the University of POITIERS in France; 

He Served as the president of a First-class Hospital in China and as the assistant director of POITIERS Hospital in France. 

He has successfully invested in a several of top-listed companies on China's A-share market(the Growth Enterprise Market (GEM) and the Science and Technology Innovation Board (STAR Market).), including Hainan Poly Pharm Co. Ltd. and SinoCellTech. 

He also served as the chairman of CWGC and the Board of supervisors of Hainan Poly Pharm Co., Ltd.

He has participated in working on the introduction and demonstration of the Shanghai Proton and Heavy Ion Center.

He has planned and assisted well-known investment institutions and enterprises in introducing Yttrium-90 nuclear therapy for liver cancer into China. 

He has also served as an independent professional investment decision-making committee member of the China Nuclear Energy Industry Corporation (CNEIC) Fund. 

Dr. Zhongxinghua founded the website called Doctormeeting, a  global cancer consultation platform, which helps oncologists with MDT consultations and new technology exchanges;

Dr. Zhongxinghua is committed to investing in, industrializing, and promoting the application of new technologies in cancer treatment


0.174844s